Remidio Innovative Solutions has launched the PRISTINE OBM 12, an automated ocular biometry and autorefraction device aimed at improving the accuracy and consistency of pediatric myopia monitoring, as the prevalence of myopia continues to rise sharply in India and globally.
Myopia currently affects nearly 30 percent of the global population and is projected to impact 50 percent by 2050. In India, childhood myopia in urban regions has increased from about 7 percent to nearly 21 percent over the past decade. Early onset myopia is associated with a higher risk of long-term complications such as retinal detachment, glaucoma, and myopic maculopathy, highlighting the need for precise and repeatable monitoring from an early age.
Managing pediatric myopia remains challenging due to difficulties in obtaining reliable measurements from young children, variability across diagnostic devices, limited access to axial length measurement tools outside tertiary hospitals, and long waiting times in high-volume clinics. Many practices continue to rely primarily on refraction, which does not adequately capture true myopia progression.
The PRISTINE OBM 12 addresses these gaps by integrating axial length measurement, full ocular biometry, and autorefraction into a single automated platform designed for pediatric use. The device captures 12 ocular parameters within seconds and supports seamless integration with electronic medical record systems, enabling objective and evidence-based monitoring.
Automatic alignment and intelligent auto-capture ensure measurements are recorded only when fixation is accurate, improving repeatability while reducing technician workload. By combining autorefraction and anterior segment biometry in a single workflow, the device reduces inter-device variability and streamlines clinical operations. Its compact design and intuitive interface allow deployment across tertiary hospitals, secondary centers, and community clinics, expanding access to high-quality pediatric eye care.
According to validation studies, the PRISTINE OBM 12 demonstrates strong agreement with established standard-of-care biometers and offers higher precision compared to manual, non-contact biometers currently in use.
By integrating axial length, biometry, and refraction into one workflow, the system enables more objective monitoring and clearer interpretation of myopia progression, supporting long-term management. The performance and automation of the device also allow high-quality myopia assessment to extend beyond specialist clinics into settings such as school screening programs and community eye care initiatives.
